[Form 4/A] Omada Health, Inc. Amended Insider Trading Activity

Rhea-AI Filing Summary

Omada Health, Inc. director Jeryl L. Hilleman reported an updated equity holding following a restricted stock unit grant and a correction to a prior filing. On 10/05/2025, Hilleman was granted 1,081 restricted stock units (RSUs) of Omada Health common stock under the company’s Non-Employee Director Compensation Program, in lieu of cash retainer fees, at a reported price of $0 per share. Each RSU represents the right to receive one share of common stock, with settlement timing determined under the program or as selected by the director. After this transaction, Hilleman beneficially owned 11,193 shares of common stock. The amendment notes that the original report overstated both the amount of securities acquired and beneficially owned by 45 shares, and this filing corrects those errors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HILLEMAN JERYL L

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
10/07/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/05/2025		A		1,081(1)(2)	A	$0	11,193(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

2. The original Form 4 filed by the Reporting Person inadvertently overstated the amount of securities acquired and beneficially owned by 45 shares. This Form 4 amendment is being filed to correct the aforementioned errors.

	/s/ Nathan Salha, as Attorney-in-Fact for Jeryl L. Hilleman	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Omada Health (OMDA) report in this Form 4/A?

Director Jeryl L. Hilleman reported the grant of 1,081 restricted stock units (RSUs) of Omada Health common stock on 10/05/2025 under the Non-Employee Director Compensation Program.

Why was this Omada Health (OMDA) insider filing amended?

The amendment states that the original report filed by the director inadvertently overstated both the amount of securities acquired and beneficially owned by 45 shares, and this filing corrects those errors.

How many Omada Health (OMDA) shares does the director beneficially own after this transaction?

Following the reported RSU grant and correction, director Jeryl L. Hilleman is shown as beneficially owning 11,193 shares of Omada Health common stock.

What are the terms of the RSUs granted to the Omada Health (OMDA) director?

Each RSU represents the right to receive one share of Omada Health common stock, with settlement to take place either on a date selected by the director under the Non-Employee Director Compensation Program or as otherwise provided by that program.

What is the relationship of the reporting person to Omada Health (OMDA)?

The reporting person, Jeryl L. Hilleman, is identified as a director of Omada Health, Inc., and the Form 4/A is filed by one reporting person.

Was any cash paid for the Omada Health (OMDA) RSU grant?

The filing lists the price for the 1,081 RSUs as $0, reflecting that these units were granted as part of the Non-Employee Director Compensation Program in lieu of retainer fees.